Working… Menu

A Study of the Safety and Efficacy of Ciclesonide in the Treatment of Non-hospitalized COVID-19 Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04377711
Recruitment Status : Completed
First Posted : May 6, 2020
Last Update Posted : April 15, 2021
Information provided by (Responsible Party):
Covis Pharma S.à.r.l.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : January 5, 2021
Actual Study Completion Date : January 5, 2021